ArticleScientific data2026
SynRXN: An Open Benchmark and Curated Dataset for Computational Reaction Modeling.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
We present SynRXN, a unified benchmark dataset resource for computer-aided synthesis planning (CASP). SynRXN decomposes end-to-end synthesis planning into five task families, covering reaction rebalancing, atom-to-atom mapping, reaction classification, reaction property prediction, and synthesis prediction. Curated, provenance-tracked reaction corpora are assembled from heterogeneous public sources into a harmonized representation and packaged as versioned datasets for each task family, with explicit source metadata, licence tags, and machine-readable manifests that record checksums and row counts. For every task, SynRXN provides predefined, leakage-aware partitions, and standardized evaluation metrics tailored to classification, regression, and structured prediction settings. For sensitive benchmarking, we combine public training and validation data with held-out gold-standard test sets, and contamination-prone tasks such as reaction rebalancing and atom-to-atom mapping are distributed only as evaluation sets and are explicitly not intended for model training. Scripted build recipes enable bitwise-reproducible regeneration of all corpora across machines and over time, and the entire resource is released under permissive open licences to support reuse and extension. By removing dataset heterogeneity and packaging transparent, reusable benchmark specifications, SynRXN enables fair longitudinal comparison of CASP methods, supports rigorous ablations and stress tests along the full reaction-informatics pipeline, and lowers the barrier for practitioners who seek robust and comparable performance estimates for real-world synthesis planning workloads.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.